Spectral Med Inc saw a notable increase in its stock price, reflecting positive investor sentiment.
Yesterday, Spectral Med Inc (EDT.TO) experienced a solid gain of 3.60%, closing at CA$1.15. This upward movement comes amidst ongoing developments in the company's product pipeline and market positioning.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$337.59M
52W high
$1.65
52W low
$1.03
1W change
-7.26%
Beta
0.18
Analyst Price Targets
Based on analyst covering EDT · as of Sep 17, 2026
Wall Street analysts forecast EDT stock price to rise 173.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+173.9% Upside
Current Price
C$1.15
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
41.8%
Annualized
90-Day Vol
31.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.96
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.08 | C$0.94 – C$1.25 |
| 60 trading days | C$1.02 | C$0.83 – C$1.25 |
| 90 trading days | C$0.96 | C$0.75 – C$1.23 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the implications of Spectral Med's recent performance and its potential future growth as the company advances its FDA applications and product commercialization.
Spectral Med Inc's stock rose by 3.60% yesterday
The market cap now stands at CA$337.59 million, reflecting investor optimism but also highlighting the company's need for sustainable growth.
Bull case
The recent gain could signal growing confidence among investors, especially as the company moves forward with its FDA filing for PMX, a therapy aimed at treating endotoxic septic shock. This progress could boost market visibility and create new revenue opportunities.
Bear case
Despite the positive movement, investors should stay cautious. The lack of recent news or updates might lead to volatility, and the company’s financial metrics, including a profit margin of 0%, raise concerns about its long-term viability.
Market Performance Overview
Advertisement
Spectral Med Inc's stock closed at CA$1.15 after a 3.60% increase yesterday, indicating a positive shift in investor sentiment. This uptick could be linked to the anticipation surrounding the company's FDA application for PMX, which aims to address a critical healthcare need.
Future Prospects
Looking ahead, a successful filing of the PMA application could significantly impact Spectral Med's market position. Investors are hopeful that advancements in their product offerings will lead to increased revenue and a stronger financial outlook.
Investor Considerations
While the recent gain is encouraging, potential investors should weigh the company's current financial health, including its lack of profit margins and the absence of recent news. Staying informed about the company's developments and market conditions is essential for understanding future stock performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
